Attendance at the "Options For The Control of Influenza VII" Conference

Retroscreen Virology Limited, a global leader in anti-viral research, clinical trials and experimental challenge studies, is pleased to announce that both Professor John Oxford, Chief Scientific Officer, and .Dr Rob Lambkin-Williams, Chief Executive Officer, will be attending the “Options For The Control of Influenza VII” conference. This conference will be held at the Hong Kong Convention and Exhibition Centre from 3-7 September 2010.

The Options conference series is held approximately every three years and is the largest meeting that brings together scientists working on all aspects of influenza, from basic science to healthcare policy. Influenza is the fastest growing segment in the adult vaccine market and is a key research area for Retroscreen, with both Professor Oxford and Dr Lambkin-Williams being recognised experts in the field.  Data generated in successful studies conducted by Retroscreen will be presented by the Company’s clients during the conference.

For further information on the conference, please visit:
www.controlinfluenza.com